Literature DB >> 7718472

Interferon-alpha in combination with corticosteroids improves systemic mast cell disease.

E Delaporte, E Piérard, B G Wolthers, P Desreumaux, A Janin, A Cortot, F Piette, H Bergoend.   

Abstract

Mesh：

Substances：

Year:  1995        PMID： 7718472     DOI： 10.1111/j.1365-2133.1995.tb08689.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN： 0007-0963            Impact factor:   9.302


× No keyword cloud information.
  4 in total

1.  Efficacy and safety of midostaurin in patients with advanced systemic mastocytosis: 10-year median follow-up of a phase II trial.

Authors:  D J DeAngelo; T I George; A Linder; C Langford; C Perkins; J Ma; P Westervelt; J D Merker; C Berube; S Coutre; M Liedtke; B Medeiros; D Sternberg; C Dutreix; P-A Ruffie; C Corless; T J Graubert; J Gotlib
Journal:  Leukemia       Date:  2017-07-24       Impact factor: 11.528

2.  Bullous mastocytosis treated with oral betamethasone therapy.

Authors:  Kaushal K Verma; Radhakrishna Bhat; Manoj K Singh
Journal:  Indian J Pediatr       Date:  2004-03       Impact factor: 1.967

3.  Hypotension, Syncope, and Fever in Systemic Mastocytosis without Skin Infiltration and Rapid Response to Corticosteroid and Cyclosporin: A Case Report.

Authors:  Didem Ozdemir; Selcuk Dagdelen; Tomris Erbas; Kemal Agbaht; Songul Serefhanoglu; Salih Aksu; Sibel Ersoy-Evans
Journal:  Case Rep Med       Date:  2010-12-20

4.  Continuous diphenhydramine infusion and imatinib for KIT-D816V-negative mast cell activation syndrome: a case report.

Authors:  Faizan Malik; Naveed Ali; Syed Imran Mustafa Jafri; Ali Ghani; Mohsin Hamid; Margot Boigon; Christian Fidler
Journal:  J Med Case Rep       Date:  2017-04-24
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.